Mission
Our mission is to develop and commercialize new and better pharmaceutical products that improve patient’s lives.
Contact : info@zylera.com
Latest Press Release
Company Hires Seasoned Executive In Parallel With New Product Launches
Research Triangle Park, NC, November 15, 2011 — Zylera Pharmaceuticals, LLC, a specialty pharmaceutical company that develops, acquires and commercializes prescription pharmaceutical products and dietary supplements and markets those products in the U.S. is pleased to announce the appointment of Matthew V. Phillips as Chief Operating Officer. Prior to joining Zylera Matt was Executive Director…
read more...
BioTech news Sales & Marketing- ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea
- Achillion Announces Executive Promotion
- PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
- CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Sales & Marketing- ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea
- Achillion Announces Executive Promotion
- PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
- CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure